**Author details**

Muhammad Jahangeer1 , Areej Riasat1 , Zahed Mahmood1 , Muhammad Numan1 , Naveed Munir1 , Mehvish Ashiq2 , Muhammad Asad1 , Usman Ali1 and Mahwish Salman1 \*

1 Department of Biochemistry, Government College University Faisalabad, Pakistan

2 Department of Chemistry, The Women University Multan, Pakistan

\*Address all correspondence to: mahwish.gene@gmail.com

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**119**

*Secondary Metabolites from* Saccharomyces cerevisiae *Species with Anticancer Potential*

217-234

020-10587-y

metabolites and their analogs as anticancer agents–from bench to bedside. Fungal Metabolites. 2016:1-32

[10] Rabha J, Jha DK. Metabolic diversity of penicillium. In: *New and Future Developments in Microbial Biotechnology and Bioengineering*. Elsevier; 2018. pp.

[11] Rahmat E, Kang Y. Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites. Applied Microbiology Biotechnology. 2020;**104**(11):4659- 4674. https://doi.org/10.1007/s00253-

[12] Rahmat E, Kang Y. Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites. Applied Microbiology and

Biotechnology. 2020:1-16

[13] Siddiqui MS, Thodey K,

Trenchard I, Smolke CD. Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools. FEMS Yeast Research. 2012;**12**(2):144-170

[14] Brown S, Clastre M, Courdavault V, O'Connor SE. De novo production of the plant-derived alkaloid

strictosidine in yeast. Proceedings of the National Academy of Sciences.

Jeon EJ, Park MK, Yim YH, Liu JR, et al. In vitro biosynthesis of strictosidine usinglonicera japonica leaf extracts and recombinant yeast. Journal of Plant

[16] Galanie S, Thodey K, Trenchard IJ, Interrante MF, Smolke CD. Complete biosynthesis of opioids in yeast. Science.

2015;**112**(11):3205-3210

[15] Nam KH, Chung HJ,

Biology. 2007;**50**(3):315-320

2015;**349**(6252):1095-1100

[17] Kaboli PJ, Rahmat A, Ismail P, Ling KH. Targets and mechanisms of

*DOI: http://dx.doi.org/10.5772/intechopen.95067*

[1] Hoffman CS, Wood V, Fantes PA. An ancient yeast for young geneticists: A primer on the Schizosaccharomyces pombe model system. Genetics.

[2] Piškur J, Langkjaer RB. Yeast genome sequencing: The power of comparative genomics. Molecular Microbiology.

**References**

2015;**201**(2):403-423

2004;*53*(2):381-389

2000;*64*(1):34-50

2006;*8*(2):E239-E253

2016;*8*(5):304-315

[3] Ostergaard S, Olsson L,

Nielsen J. Metabolic engineering of Saccharomyces cerevisiae. Microbiology

[4] Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. The AAPS Journal.

[5] Al-Jassaci MJ, Mohammed GJ, Hameed IH. Secondary metabolites analysis of saccharomyces cerievisiae and evaluation of antibacterial activity. International Journal of Pharmaceutical and Clinical Research.

[6] Park SR, Yoon YJ, Pham JV,

2015;**5**(105):86665-86674

2016;65(6):154-158

Yilma MA, Feliz A, Majid MT, et al. A review of the microbial production of bioactive natural products and biologics. Frontiers in Microbiology. 2019;*10*:1404

[7] Fidan O, Zhan J. Recent advances in engineering yeast for pharmaceutical protein production. RSC Advances.

[8] Thomas DL, Sharp TM, Torres J, Armstrong PA, Munoz-Jordan J, Ryff KR, et al. Local transmission of zika virus—puerto rico. Morbidity and Mortality Weekly Report. November 23, 2015–January 28, 2016.

[9] Banerjee S, Paruthy SB. Preclinical and clinical perspective on fungal

and Molecular Biology Reviews.

*Secondary Metabolites from* Saccharomyces cerevisiae *Species with Anticancer Potential DOI: http://dx.doi.org/10.5772/intechopen.95067*
